Literature DB >> 12401406

Inflammation and immune responses in atherosclerosis.

David R Greaves1, Keith M Channon.   

Abstract

Recent studies have highlighted the role of inflammatory mediators and the cells of the innate and adaptive immune response in the initiation, growth and rupture of atherosclerotic plaques. Viewing this form of vascular pathology as a modified form of chronic inflammation suggests new avenues for therapeutic intervention in cardiovascular disease.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12401406     DOI： 10.1016/s1471-4906(02)02331-1

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  26 in total

Review 1.  The in and out of monocytes in atherosclerotic plaques: Balancing inflammation through migration.

Authors:  Burkhard Ludewig; Jon D Laman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

2.  Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6.

Authors:  Zhongyang Lu; Yanchun Li; Junfei Jin; Xiaoming Zhang; Maria F Lopes-Virella; Yan Huang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

3.  Reduction of heat shock protein antibody levels by statin therapy.

Authors:  María C Guisasola; Elena Dulín; Jesús Almendral; Pedro García-Barreno
Journal:  Lipids       Date:  2008-11-26       Impact factor: 1.880

4.  Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model.

Authors:  C Bodet; F Chandad; D Grenier
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

5.  Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction.

Authors:  Bokai Lei; Weibin Zha; Yun Wang; Cong Wen; Elaine J Studer; Xuan Wang; Fang Jin; Guangji Wang; Luyong Zhang; Huiping Zhou
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

6.  Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients.

Authors:  M Clemente-Postigo; M I Queipo-Ortuño; M Murri; M Boto-Ordoñez; P Perez-Martinez; C Andres-Lacueva; F Cardona; F J Tinahones
Journal:  J Lipid Res       Date:  2012-03-05       Impact factor: 5.922

7.  Fatty acids from very low-density lipoprotein lipolysis products induce lipid droplet accumulation in human monocytes.

Authors:  Laura J den Hartigh; Jaime E Connolly-Rohrbach; Samantha Fore; Thomas R Huser; John C Rutledge
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

8.  Illness perceptions among cardiac patients: relation to depressive symptomatology and sex.

Authors:  Sherry L Grace; Suzan Krepostman; Dina Brooks; Heather Arthur; Pat Scholey; Neville Suskin; Susan Jaglal; Beth L Abramson; Donna E Stewart
Journal:  J Psychosom Res       Date:  2005-09       Impact factor: 3.006

9.  Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis.

Authors:  P Margutti; F Delunardo; M Sorice; G Valesini; C Alessandri; R Capoano; E Profumo; A Siracusano; B Salvati; R Riganò; E Ortona
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.

Authors:  L Zhao; T Ding; T Cyrus; Y Cheng; H Tian; M Ma; R Falotico; D Praticò
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.